StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
8
Publishing Date
2021 - 10 - 25
1
2021 - 08 - 02
1
2021 - 06 - 01
1
2021 - 03 - 11
1
2020 - 12 - 29
1
2020 - 11 - 17
1
2020 - 10 - 09
1
2020 - 10 - 07
1
Sector
Health technology
8
Tags
Agonist
2
America
2
Application
2
Award
2
Awards
2
Biopharma
2
Business
4
Cancer
12
Commercialization
2
Conference
17
Congress
4
Depression
2
Designation
4
Disease
2
Drug
5
Earnings
5
Europe
6
Events
3
Fast track
2
Fast track designation
2
Fda
8
Fda fast track
2
Financial
14
Financial results
10
Genetown
2
Global
3
Grants
4
Health
3
Immunotherapy
2
International
2
J.p. morgan healthcare conference
2
Lybalvi
3
Market
7
Meeting
3
N/a
130
Nemvaleukin
13
News
4
Order
2
Ovarian cancer
3
People
4
Pharma
2
Phase 3
2
Positive
2
Presentation
5
Program
8
Report
17
Research
14
Results
31
Schizophrenia
7
Study
3
Submission
2
Symposium
2
Teva
2
Therapeutics
6
Therapy
4
Topline
2
Treatment
12
Trial
3
World
2
Year
2
Entities
22nd century group, inc
10
Abbott laboratories
79
Abbvie inc.
42
Acer therapeutics inc.
12
Adma biologics inc
18
Amgen inc.
23
Amneal pharmaceuticals, inc.
15
Ani pharmaceuticals, inc.
17
Apyx medical corporation
12
Aquestive therapeutics, inc.
15
Ardelyx, inc.
11
Arrival
10
Astellas pharma inc
17
Avenue therapeutics, inc.
10
Becton, dickinson and company
13
Beigene, ltd.
16
Biogen inc.
32
Biomarin pharmaceutical inc.
10
Biontech se
24
Bluebird bio, inc.
13
Boston scientific corporation
11
Brainstorm cell therapeutics inc.
14
Bristol-myers squibb company
20
Coherus biosciences, inc.
23
Eagle pharmaceuticals, inc.
11
Eli lilly and company
71
Eyenovia, inc.
13
Fortress biotech, inc.
14
Gilead sciences, inc.
21
Glaxosmithkline plc
14
Incyte corporation
23
Inhibikase therapeutics, inc.
10
Ionis pharmaceuticals, inc.
13
Jaguar health, inc.
16
Johnson & johnson
226
Medtronic plc
28
Merck & company, inc.
36
Mesoblast limited
15
Moderna, inc.
13
Novartis ag
28
Novavax, inc.
11
Novo nordisk a/s
11
Ocugen, inc.
15
Orange
63
Perrigo company
90
Pfizer, inc.
74
Reata pharmaceuticals, inc.
12
Regeneron pharmaceuticals, inc.
50
Sanofi
236
Seagen inc.
10
Soligenix, inc.
14
Sorrento therapeutics, inc.
21
T2 biosystems, inc.
14
Takeda pharmaceutical company limited
17
Teva pharmaceutical industries ltd
22
Thermo fisher scientific inc
16
Tonix pharmaceuticals holding corp.
12
Verrica pharmaceuticals inc.
13
Vertex pharmaceuticals incorporated
14
Veru inc.
14
Symbols
ALKS
8
LLY
1
Exchanges
Nasdaq
8
Nyse
1
Crawled Date
2021 - 10 - 25
1
2021 - 08 - 02
1
2021 - 06 - 01
1
2021 - 03 - 11
1
2020 - 12 - 29
1
2020 - 12 - 15
3
Crawled Time
10:21
3
11:00
2
12:00
1
12:07
2
Source
investor.alkermes.com
6
www.biospace.com
1
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Fda
entities :
Alkermes plc
save search
Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa in Combination With Pembrolizumab for the Treatment of Platinum-Resistant Ovarian Cancer
Published:
2021-10-25
(Crawled : 11:00)
- investor.alkermes.com
ALKS
|
News
|
$23.78
-0.96%
-0.97%
1.8M
|
Health Technology
|
-20.8%
|
O:
2.22%
H:
2.22%
C:
2.15%
treatment
fda
fda fast track
fast track
cancer
nemvaleukin
ovarian cancer
fast track designation
designation
Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma
Published:
2021-08-02
(Crawled : 12:00)
- biospace.com/
ALKS
|
News
|
$23.78
-0.96%
-0.97%
1.8M
|
Health Technology
|
-5.52%
|
O:
2.62%
H:
3.09%
C:
2.82%
treatment
fda
fda fast track
fast track
nemvaleukin
mucosal melanoma
fast track designation
designation
Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophrenia and Bipolar I Disorder
Published:
2021-06-01
(Crawled : 11:00)
- investor.alkermes.com
LLY
|
News
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
275.87%
|
O:
0.29%
H:
0.28%
C:
-0.95%
ALKS
|
News
|
$23.78
-0.96%
-0.97%
1.8M
|
Health Technology
|
6.4%
|
O:
0.79%
H:
1.4%
C:
1.31%
treatment
fda
schizophrenia
fda approval
approval
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
Published:
2021-03-11
(Crawled : 12:07)
- investor.alkermes.com
ALKS
|
News
|
$23.78
-0.96%
-0.97%
1.8M
|
Health Technology
|
25.63%
|
O:
1.56%
H:
1.79%
C:
-0.1%
treatment
fda
drug
designation
FDA Accepts Alkermes' Resubmission of New Drug Application for ALKS 3831
Published:
2020-12-29
(Crawled : 12:07)
- prnewswire.com
ALKS
|
News
|
$23.78
-0.96%
-0.97%
1.8M
|
Health Technology
|
13.51%
|
O:
3.39%
H:
0.14%
C:
-5.51%
drug
fda
submission
fda acceptance
new drug
application
resubmission
Alkermes Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on ALKS 3831
Published:
2020-10-07
(Crawled : 10:21)
- investor.alkermes.com
ALKS
|
News
|
$23.78
-0.96%
-0.97%
1.8M
|
Health Technology
|
50.94%
|
O:
0.63%
H:
6.28%
C:
5.35%
fda
FDA Advisory Committee Votes in Support of ALKS 3831 for the Treatment of Schizophrenia and Bipolar I Disorder
Published:
2020-10-09
(Crawled : 10:21)
- investor.alkermes.com
ALKS
|
News
|
$23.78
-0.96%
-0.97%
1.8M
|
Health Technology
|
Email alert
Add to watchlist
fda
schizophrenia
treatment
Alkermes Receives FDA Complete Response Letter Related to ALKS 3831 Manufacturing Records Review
Published:
2020-11-17
(Crawled : 10:21)
- investor.alkermes.com
ALKS
|
News
|
$23.78
-0.96%
-0.97%
1.8M
|
Health Technology
|
35.2%
|
O:
0.84%
H:
2.22%
C:
1.7%
fda
response
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.